Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP599512.RAXeaR0ooyWZtoIaWk2o5KTm4oyiFVI-5GScaE__Ry1Xw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP599512.RAXeaR0ooyWZtoIaWk2o5KTm4oyiFVI-5GScaE__Ry1Xw130_assertion type Assertion NP599512.RAXeaR0ooyWZtoIaWk2o5KTm4oyiFVI-5GScaE__Ry1Xw130_head.
- NP599512.RAXeaR0ooyWZtoIaWk2o5KTm4oyiFVI-5GScaE__Ry1Xw130_assertion description "[Roughly 40% of ovarian endometrioid adenocarcinomas (OEA) have constitutive activation of Wnt signaling as a result of oncogenic mutations in the beta-catenin protein or inactivating mutations in key negative regulators of beta-catenin, such as the adenomatous polyposis coli and Axin tumor suppressor proteins.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP599512.RAXeaR0ooyWZtoIaWk2o5KTm4oyiFVI-5GScaE__Ry1Xw130_provenance.
- NP599512.RAXeaR0ooyWZtoIaWk2o5KTm4oyiFVI-5GScaE__Ry1Xw130_assertion evidence source_evidence_literature NP599512.RAXeaR0ooyWZtoIaWk2o5KTm4oyiFVI-5GScaE__Ry1Xw130_provenance.
- NP599512.RAXeaR0ooyWZtoIaWk2o5KTm4oyiFVI-5GScaE__Ry1Xw130_assertion SIO_000772 16452189 NP599512.RAXeaR0ooyWZtoIaWk2o5KTm4oyiFVI-5GScaE__Ry1Xw130_provenance.
- NP599512.RAXeaR0ooyWZtoIaWk2o5KTm4oyiFVI-5GScaE__Ry1Xw130_assertion wasDerivedFrom befree-20140225 NP599512.RAXeaR0ooyWZtoIaWk2o5KTm4oyiFVI-5GScaE__Ry1Xw130_provenance.
- NP599512.RAXeaR0ooyWZtoIaWk2o5KTm4oyiFVI-5GScaE__Ry1Xw130_assertion wasGeneratedBy ECO_0000203 NP599512.RAXeaR0ooyWZtoIaWk2o5KTm4oyiFVI-5GScaE__Ry1Xw130_provenance.